JP2022517698A5 - - Google Patents

Info

Publication number
JP2022517698A5
JP2022517698A5 JP2021563434A JP2021563434A JP2022517698A5 JP 2022517698 A5 JP2022517698 A5 JP 2022517698A5 JP 2021563434 A JP2021563434 A JP 2021563434A JP 2021563434 A JP2021563434 A JP 2021563434A JP 2022517698 A5 JP2022517698 A5 JP 2022517698A5
Authority
JP
Japan
Prior art keywords
referred
sequence
sar
peptide ligand
ligand according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021563434A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022517698A (ja
Filing date
Publication date
Priority claimed from GBGB1900528.9A external-priority patent/GB201900528D0/en
Application filed filed Critical
Publication of JP2022517698A publication Critical patent/JP2022517698A/ja
Publication of JP2022517698A5 publication Critical patent/JP2022517698A5/ja
Pending legal-status Critical Current

Links

JP2021563434A 2019-01-15 2020-01-15 インテグリンαvβ3に特異的な二環式ペプチドリガンド Pending JP2022517698A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1900528.9A GB201900528D0 (en) 2019-01-15 2019-01-15 Bicyclic peptide ligands specific for integrin AVB3
GB1900528.9 2019-01-15
PCT/GB2020/050072 WO2020148528A1 (en) 2019-01-15 2020-01-15 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR INTEGRIN αVβ3

Publications (2)

Publication Number Publication Date
JP2022517698A JP2022517698A (ja) 2022-03-09
JP2022517698A5 true JP2022517698A5 (OSRAM) 2023-01-25

Family

ID=65528176

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021563434A Pending JP2022517698A (ja) 2019-01-15 2020-01-15 インテグリンαvβ3に特異的な二環式ペプチドリガンド

Country Status (6)

Country Link
US (1) US20220119488A1 (OSRAM)
EP (1) EP3965892A1 (OSRAM)
JP (1) JP2022517698A (OSRAM)
CN (1) CN113613728A (OSRAM)
GB (1) GB201900528D0 (OSRAM)
WO (1) WO2020148528A1 (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102754019B1 (ko) 2014-10-29 2025-01-14 바이시클러드 리미티드 Mt1-mmp에 특이적인 바이사이클릭 펩타이드 리간드
CN111032678A (zh) 2017-06-26 2020-04-17 拜西克尔德有限公司 具有可检测部分的双环肽配体和其用途
ES2926195T3 (es) 2017-08-04 2022-10-24 Bicycletx Ltd Ligandos peptídicos bicíclicos específicos de CD137
AU2019224659A1 (en) 2018-02-23 2020-10-15 Bicycletx Limited Multimeric bicyclic peptide ligands
US11180531B2 (en) 2018-06-22 2021-11-23 Bicycletx Limited Bicyclic peptide ligands specific for Nectin-4
GB201820288D0 (en) 2018-12-13 2019-01-30 Bicycle Tx Ltd Bicycle peptide ligaands specific for MT1-MMP
GB201820295D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for MT1-MMP
GB201820325D0 (en) 2018-12-13 2019-01-30 Bicyclerd Ltd Bicyclic peptide ligands specific for psma
CN113474045A (zh) 2018-12-21 2021-10-01 拜斯科技术开发有限公司 Pd-l1特异性的双环肽配体
US12551567B2 (en) 2018-12-21 2026-02-17 Bicyclerd Limited Bicyclic peptide ligands specific for PD-L1
GB201900529D0 (en) 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for CD38
TWI860386B (zh) 2019-07-30 2024-11-01 英商拜西可泰克斯有限公司 異質雙環肽複合物
CA3189761A1 (en) 2020-08-03 2022-02-10 Gemma Mudd Peptide-based linkers
BR102021016135A2 (pt) * 2021-08-16 2023-02-23 Novageia Biotecnologia Ltda Antagonistas miméticos macrocíclicos com atividade biológica, seus usos e composições
CN114656525B (zh) * 2022-04-25 2024-02-02 合肥师范学院 用于癌细胞整合素的rgd环肽及其在制备肿瘤药物中的应用
WO2026002154A1 (en) * 2024-06-27 2026-01-02 Syneron Opal Cell penetrating peptide compounds and using thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1452868A2 (en) 2003-02-27 2004-09-01 Pepscan Systems B.V. Method for selecting a candidate drug compound
PT1844337E (pt) 2005-01-24 2014-04-03 Pepscan Systems Bv Compostos ligantes, compostos imunogénicos e peptidomiméticos
WO2009098450A2 (en) 2008-02-05 2009-08-13 Medical Research Council Methods and compositions
WO2011079015A1 (en) * 2009-12-21 2011-06-30 The Regents Of The University Of California Rgd-containing cyclic peptides
KR102754019B1 (ko) * 2014-10-29 2025-01-14 바이시클러드 리미티드 Mt1-mmp에 특이적인 바이사이클릭 펩타이드 리간드
CN111032678A (zh) * 2017-06-26 2020-04-17 拜西克尔德有限公司 具有可检测部分的双环肽配体和其用途
GB201810329D0 (en) * 2018-06-22 2018-08-08 Bicycletx Ltd Peptide ligands for binding to integrin avB3
GB201900527D0 (en) * 2019-01-15 2019-03-06 Bicycletx Ltd Bicyclic peptide ligands specific for integrin avb3

Similar Documents

Publication Publication Date Title
JP2022518210A5 (OSRAM)
JP2022517442A5 (OSRAM)
JP2022518695A5 (OSRAM)
JP2022517040A5 (OSRAM)
JP2022512478A5 (OSRAM)
JP2022514687A5 (OSRAM)
JP2022514255A5 (OSRAM)
JP2022513223A5 (OSRAM)
JP2022552839A5 (OSRAM)
JP2022544058A5 (OSRAM)
US10688175B2 (en) NSP10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications
JP2022532134A5 (OSRAM)
JP2022515720A5 (OSRAM)
US8906355B2 (en) Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof
AR025307A1 (es) Compuesto de liberacion sostenida de un peptido, microparticulas, composicion farmaceutica y el uso de dicho compuesto para la fabricacion de un medicamento
Redman et al. Pharmacokinetic and chemical synthesis optimization of a potent D-peptide HIV entry inhibitor suitable for extended-release delivery
Han et al. Protein-based biomaterials for combating viral infections: current status and future prospects for development
JP2024515306A5 (OSRAM)
JP4563806B2 (ja) P−セレクチンに対する結合性化合物
JP2007506713A (ja) 例えば、抗血管新生活性を有するペプチドおよび治療におけるその適用
JP2022515721A5 (OSRAM)
JP4227520B2 (ja) P−セレクチンに対して選択的に結合するペプチド化合物
JP7766489B2 (ja) 免疫調節特性を有するペプチド
WO2003026700A2 (fr) Compositions pour la vectorisation d'anticorps a travers la barriere hematoencephalique et leur utilisation pour le diagnostic ou le traitement des maladies du systeme nerveux central
JP2004538272A5 (OSRAM)